Patrick Plewman Biography and Net Worth

SVPfor Diagnostic Services of Quest Diagnostics

Patrick Plewman is Senior Vice President for Diagnostic Services.

In this new role, he is responsible for growing a portfolio of data driven analytics and services businesses, which enable employers, providers, and others to deliver health care more effectively and efficiently. This portfolio includes Employer Population Health, Employer Solutions, ExamOne, Healthcare Analytic Solutions, and the recently acquired Pack Health.

Patrick had led Quest’s West region as Vice President and General Manager. Since joining the company in 2013, he has led several of Quest’s clinical diagnostic franchises.

Prior to joining Quest, he held executive, business development and strategy roles in molecular diagnostics at SmithKline Beecham and diaDexus.

Patrick earned a bachelor’s degree with distinction in chemistry and political science from the University of North Carolina at Chapel Hill, where he made Phi Beta Kappa and was a Morehead-Cain Scholar. He holds an MBA from Harvard Business School.

What is Patrick Plewman's net worth?: The estimated net worth of Patrick Plewman is at least $2.81 million as of August 21st, 2025. Mr. Plewman owns 15,269 shares of Quest Diagnostics stock worth more than $2,813,573 as of December 5th. This net worth evaluation does not reflect any other investments that Mr. Plewman may own. Learn More about Patrick Plewman's net worth.
How do I contact Patrick Plewman?: The corporate mailing address for Mr. Plewman and other Quest Diagnostics executives is 500 PLAZA DRIVE, SECAUCUS NJ, 07094. Quest Diagnostics can also be reached via phone at (973) 520-2700 and via email at [email protected]. Learn More on Patrick Plewman's contact information.
Has Patrick Plewman been buying or selling shares of Quest Diagnostics?: Patrick Plewman has not been actively trading shares of Quest Diagnostics in the last ninety days. Most recently, Patrick Plewman sold 1,975 shares of the business's stock in a transaction on Thursday, August 21st. The shares were sold at an average price of $185.00, for a transaction totalling $365,375.00. Following the completion of the sale, the senior vice president now directly owns 15,269 shares of the company's stock, valued at $2,824,765. Learn More on Patrick Plewman's trading history.
Who are Quest Diagnostics' active insiders?: Quest Diagnostics' insider roster includes J. Davis (CEO), Mark Delaney (SVP), Michael Deppe (CAO), Catherine Doherty (SVP), Vicky Gregg (Director), Mark Guinan (CFO), Karthik Kuppusamy (SVP), Gary Pfeiffer (Director), Patrick Plewman (SVPfor Diagnostic Services), Michael Prevoznik (SVP), Timothy Ring (Director), Stephen Rusckowski (CEO), Daniel Stanzione (Director), and Gail Wilensky (Director). Learn More on Quest Diagnostics' active insiders.
Are insiders buying or selling shares of Quest Diagnostics?: In the last twelve months, insiders at the medical research company sold shares 24 times. They sold a total of 175,734 shares worth more than $31,849,947.70. The most recent insider tranaction occured on November, 25th when CEO J. E Davis sold 55,093 shares worth more than $10,589,976.46. Insiders at Quest Diagnostics own 8.2% of the company. Learn More about insider trades at Quest Diagnostics.
Information on this page was last updated on 11/25/2025.

Patrick Plewman Insider Trading History at Quest Diagnostics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/21/2025	Sell	1,975	$185.00	$365,375.00	15,269
8/19/2025	Sell	4,532	$183.00	$829,356.00	17,244
8/15/2025	Sell	1,975	$180.00	$355,500.00	17,244
8/6/2025	Sell	5,535	$175.00	$968,625.00	19,219

Patrick Plewman Buying and Selling Activity at Quest Diagnostics

Quest Diagnostics Company Overview

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Today's Range

Now: $184.27

$182.25

$185.12

50 Day Range

MA: $184.07

$174.90

$192.41

2 Week Range

Now: $184.27

$148.70

$197.55

Volume

1,044,858 shs

Average Volume

1,125,294 shs

Market Capitalization

$20.50 billion

P/E Ratio

21.63

Dividend Yield

1.75%

Beta

0.62